Exchange: NASDAQ·Updated 07:30 PM EDT
RNAC logo

RNAC Selecta Biosciences Inc

$8.00
$0.17
(2.16%)
Today
Closed $8.03
$0.03
(0.37%)
After Hours
EarningsNov 5
Mkt Cap$242.95M
Vol211,661.00

About RNAC

Cartesian Therapeutics, Inc. is a clinical-stage biotechnology company, which engages in mRNA cell therapies for the treatment of autoimmune diseases. It operates in research and development of cell therapy product candidates. The company was founded on December 10, 2007 is headquartered in Frederick, MD.
47

Neutral Sentiment

How do you feel about RNAC?

AllezAlejandro
$RNAC Might be time to accumulate: - Phase 3 readout in 3-6 months - Strong phase 2b results, peer reviewed in Nature Medicine - Analyst average target is 4.4x current value - Quiet in here and on Reddit, muted volume, I’d say retail hasn’t spotted the setup yet Could be a fun few months.

Advertisement|Remove ads.